IN8bio Inc (NASDAQ:INAB)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 0.00. At the close of trading, the stock’s price was $0.31, to imply an increase of 3.00% or $0.01 in intraday trading. The INAB share’s 52-week high remains $2.48, putting it -700.0% down since that peak but still an impressive 29.03% since price per share fell to its 52-week low of $0.22. The company has a valuation of $22.39M, with an average of 0.91 million shares in intraday trading volume over the past 10 days and average of 1.17 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for IN8bio Inc (INAB), translating to a mean rating of 1.40. Of 2 analyst(s) looking at the stock, 0 analyst(s) give INAB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.08.
IN8bio Inc (NASDAQ:INAB) trade information
After registering a 3.00% upside in the last session, IN8bio Inc (INAB) has traded red over the past five days. The 5-day price performance for the stock is 1.41%, and -7.40% over 30 days. With these gigs, the year-to-date price performance is -77.61%. Short interest in IN8bio Inc (NASDAQ:INAB) saw shorts transact 1.0 million shares and set a 0.51 days time to cover.
IN8bio Inc (INAB) estimates and forecasts
Looking at statistics comparing IN8bio Inc share performance against respective industry, we note that the company has outperformed competitors. IN8bio Inc (INAB) shares are -76.94% down over the last 6 months, with its year-to-date growth rate higher than industry average at 44.00% against 17.50%.
INAB Dividends
IN8bio Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
IN8bio Inc (NASDAQ:INAB)’s Major holders
IN8bio Inc insiders hold 21.56% of total outstanding shares, with institutional holders owning 46.46% of the shares at 59.23% float percentage. In total, 46.46% institutions holds shares in the company, led by AIGH CAPITAL MANAGEMENT LLC. As of 2024-06-30, the company held over 2.13 million shares (or 4.9157% of shares), all amounting to roughly $1.8 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 1.42 million shares, or about 3.2892% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $1.21 million.
